These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 14214387)

  • 1. IMMUNOLOGIC STUDIES OF PURIFIED VIRAL HEMAGGLUTININ.
    TONG MJ; FONG J
    J Immunol; 1964 Jul; 93():35-44. PubMed ID: 14214387
    [No Abstract]   [Full Text] [Related]  

  • 2. Influenza vaccines purified by zonal ultracentrifugation.
    Filczak K; Semkow R; Wrzos H; Zakrzewski K; Zgorzelska K
    Acta Microbiol Pol A; 1973; 5(3):261-70. PubMed ID: 4769561
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 4. PARTIAL IMMUNOLOGICAL UNRESPONSIVENESS TO VIRUS ANTIGENS IN GUINEA-PIGS.
    SCHWARTZ J; KLETTER J; KLOPSTOCK A
    Int Arch Allergy Appl Immunol; 1964; 25():83-8. PubMed ID: 14235475
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants.
    Závadová H; Adam E; Vonka V; Domorázková E; Kratochvílová M; Burian V; Davenport FM
    Arch Gesamte Virusforsch; 1972; 36(1):53-61. PubMed ID: 5062439
    [No Abstract]   [Full Text] [Related]  

  • 6. STUDIES OF PARAINFLUENZA VIRUSES. 3. ANTIBODY RESPONSES OF DIFFERENT ANIMAL SPECIES AFTER IMMUNIZATION.
    HSIUNG GD; CHANG PW; CUADRADO RR; ISACSON P
    J Immunol; 1965 Jan; 94():67-73. PubMed ID: 14256977
    [No Abstract]   [Full Text] [Related]  

  • 7. Purified influenza virus vaccine. A study of viral reactivity and antigenicity.
    Peck FB
    JAMA; 1968 Dec; 206(10):2277-82. PubMed ID: 5696082
    [No Abstract]   [Full Text] [Related]  

  • 8. THE BROADENING OF ANTIBODY SPECTRA FOLLOWING MULTIPLE EXPOSURES TO INFLUENZA VIRUSES.
    HENLE W; LIEF FS
    Am Rev Respir Dis; 1963 Sep; 88():SUPPL 379-86. PubMed ID: 14064952
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years.
    Závadová H; Vonka V; Adam E; Domorázková E; Davenport FM
    Arch Gesamte Virusforsch; 1972; 36(1):43-52. PubMed ID: 4551961
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunizing effect of different cleavage products from influenza viruses].
    Lange FC
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):390-1. PubMed ID: 5523686
    [No Abstract]   [Full Text] [Related]  

  • 11. [DYNAMICS OF SEROLOGICAL INDICES OF IMMUNITY IN ANIMALS IMMUNIZED WITH VACCINES AGAINST TICK-BORNE ENCEPHALITIS].
    LVOV DK; ZAKLINSKAIA VA; FOKINA KV
    Vopr Virusol; 1963; 29():420-7. PubMed ID: 14071278
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody response to influenza virus enzyme in man.
    Davenport FM; Minuse E; Hennessy AV
    Arch Environ Health; 1970 Sep; 21(3):307-11. PubMed ID: 5504431
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioimmunoprecipitation assay for quantitation of serum antibody to the hemagglutinin of type A influenza virus.
    Six HR; Kasel JA
    J Clin Microbiol; 1978 Feb; 7(2):165-71. PubMed ID: 564916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ENHANCED AVIDITY OF INFLUENZA ANTIBODIES AFTER REPEATED CONTACT OF MEN AND ANIMALS WITH A2 INFLUENZA VIRUS.
    ALEXANDROVA GI; YABROV AA; SMORODINTSEV AA
    Acta Virol; 1964 Sep; 8():385-95. PubMed ID: 14209622
    [No Abstract]   [Full Text] [Related]  

  • 15. A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.
    Wodal W; Falkner FG; Kerschbaum A; Gaiswinkler C; Fritz R; Kiermayr S; Portsmouth D; Savidis-Dacho H; Coulibaly S; Piskernik C; Hohenadl C; Howard MK; Kistner O; Barrett PN; Kreil TR
    Vaccine; 2012 Jun; 30(31):4625-31. PubMed ID: 22580355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [STUDY OF THE INTERACTION AMONG THE "TRANSITIONAL STRAINS" OF THE INFLUENZA VIRUS A2 AND THAT IN THE SERA OF NORMAL GUINEA PIGS CONTAINING INHIBITOR].
    JANDASEK L
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():44-8. PubMed ID: 14128978
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic relationship between influenza C viruses.
    Chakraverty P
    Arch Virol; 1978; 58(4):341-8. PubMed ID: 104696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of influenza virus hemagglutinin, neuraminidase and their antibody responses in infected patients.
    Chen SH; Huang CH; Yang YJ; Hsia S
    Taiwan Yi Xue Hui Za Zhi; 1973 Jun; 72(6):319-24. PubMed ID: 4519978
    [No Abstract]   [Full Text] [Related]  

  • 20. Respiratory virus vaccines. IV. Heptavalent respiratory syncytial-parainfluenza-mycoplasma-influenza vaccine in institutionalized persons.
    Woodhour AF; Sweet BH; Tytell AA; Potash L; Stokes J; Weibel RE; Metzgar DP; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):350-61. PubMed ID: 4288225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.